Table 2.
Parameter | Control group n = 37 |
AP n = 32 |
---|---|---|
GSH concentration [nmol/mL] | 448.0 | 135.8∗ |
Standard deviation | 87.2 | 46.5 |
Median | 432.9 | 140.5 |
Range | 320.2–661.4 | 54.2–228.5 |
SH group concentration [umol/L] | 294.3 | 219.0 |
Standard deviation | 54.9 | 45.1 |
Median | 309.0 | 227.0 |
Range | 215.0–415.0 | 157.0–265.0 |
MT concentration [ng/mL] | 1.2 | 2.4∗ |
Standard deviation | 1.0 | 1.4 |
Median | 0.8 | 2.1 |
Range | 0.1–3.4 | 0.3–5.0 |
Cu/Zn ratio | 0.7 | 0.9 |
Standard deviation | 0.3 | 0.2 |
Median | 0.8 | 0.9 |
Range | 0.3–1.2 | 0.5–1.3 |
GPx activity [nmol/min/mL] | 41.6 | 66.9∗ |
Standard deviation | 3.8 | 17.9 |
Median | 41.0 | 66.3 |
Range | 36.3–49.7 | 33.1–86.8 |
Cu/Zn SOD activity [nmol/min/mL] | 1.7 | 1.8 |
Standard deviation | 0.3 | 0.5 |
Median | 1.7 | 1.7 |
Range | 0.9–2.2 | 0.8–2.6 |
TRAP concentration [umol/L] | 1412.1 | 1268.7 |
Standard deviation | 386.7 | 163.4 |
Median | 1340.0 | 1233.0 |
Range | 809.0–2097.0 | 1126.0–1447.0 |
TBARS concentration [umol/L] | 2.3 | 4.4∗ |
Standard deviation | 0.9 | 2.9 |
Median | 2.3 | 3.7 |
Range | 0.4–4.5 | 1.5–10.7 |
*Statistically significant compared to control group.